PROK
ProKidney Corp.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Last price
1.59
▲ 0.17 (11.97%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Tool
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
1.45
Prev close
1.42
Day high
1.62
Day low
1.43
Volume
1.73M
Market cap
$642.68M
P/E (TTM)
—
52W range
1.30 – 3.48
Day trading desk
Gap from prior close
+2.45%
Prior close 1.42
VWAP
1.54
+3.07% from price
Relative volume
1.38×
Normal
Session range
18.98%
1.37 – 1.63
Position in range
85%
Near session high
ATR (14D)
0.11
7.01% of price
Prior day high
1.47
PDH
Prior day low
1.38
PDL
Bid / ask spread
—
Quote not published
Session volume
1.73M
Avg 1.26M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+21.05%
+22.4%
1M
+5.92%
+2.2%
3M
-8.00%
-11.1%
6M
-22.97%
-34.0%
YTD
-28.12%
-40.4%
1Y
-29.39%
-49.4%
3Y
-84.37%
-158.5%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PROK open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
97.05M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 4, 26 | PEREIRA BRIAN J G Director |
— | 757.16K | — | |
| Jun 12, 26 | GIROLAMO TODD C. J.D. Officer |
— | 163.86K | — | Direct |
| Apr 28, 26 | CONTROL EMPRESARIAL DE CAPITALES, S.A. DE C.V. Beneficial Owner of more than 10% of a Class of Security |
— | 63.12M | — | Indirect |
| Nov 13, 25 | PEREIRA BRIAN J G Director |
SELL | 757.16K | $1.88M | Indirect |
| Jul 8, 25 | WEBER DARIN J. Officer |
SELL | 103.48K | $312.51K | Direct |
| Jun 3, 25 | LEGORRETA PABLO G Director and Beneficial Owner of more than 10% of a Class of Security |
— | 3.82M | — | Indirect |
| Apr 22, 25 | CONTROL EMPRESARIAL DE CAPITALES, S.A. DE C.V. Beneficial Owner of more than 10% of a Class of Security |
BUY | 387.39K | $276.37K | Direct |
| Apr 17, 25 | CONTROL EMPRESARIAL DE CAPITALES, S.A. DE C.V. Beneficial Owner of more than 10% of a Class of Security |
BUY | 25.00K | $18.69K | Direct |
| Apr 16, 25 | CONTROL EMPRESARIAL DE CAPITALES, S.A. DE C.V. Beneficial Owner of more than 10% of a Class of Security |
BUY | 100.00K | $74.82K | Direct |
| Apr 15, 25 | CONTROL EMPRESARIAL DE CAPITALES, S.A. DE C.V. Beneficial Owner of more than 10% of a Class of Security |
BUY | 736.11K | $520.60K | Direct |
| Apr 11, 25 | CONTROL EMPRESARIAL DE CAPITALES, S.A. DE C.V. Beneficial Owner of more than 10% of a Class of Security |
BUY | 1.03M | $628.85K | Direct |
| Feb 4, 25 | PEREIRA BRIAN J G Director |
— | 757.16K | — | |
| Feb 4, 25 | LEGORRETA PABLO G Director and Beneficial Owner of more than 10% of a Class of Security |
— | 532.53K | — | Indirect |
| Sep 19, 24 | WEBER DARIN J. Officer |
SELL | 16.41K | $41.03K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CONTROL EMPRESARIAL DE CAPITALES, S.A. DE C.V. |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
GIROLAMO TODD C. J.D. |
Officer | 327.71K | Conversion of Exercise of derivative security |
LEGORRETA PABLO G |
Director and Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
PEREIRA BRIAN J G |
Director | — | Conversion of Exercise of derivative security |
WEBER DARIN J. |
Officer | 0 | Sale |
Fundamentals
Market cap$642.68M
Enterprise value$1.26B
Revenue (TTM)$818.00K
Gross profit$818.00K
EBITDA$-170.37M
Net income$-84.16M
EPS (TTM)$-0.55
Free cash flow$-83.84M
Total cash$181.56M
Total debt$3.52M
Book value / share$-4.30
Shares outstanding208.93M
Float160.49M
Short % of float13.65%
Dividend yield—
Beta (5Y)1.72
Valuation & profitability ratios
Trailing P/E—
Forward P/E-2.75
PEG ratio—
Price / sales—
Price / book—
EV / revenue1,546.09
EV / EBITDA-7.42
Gross margin100.00%
Operating margin-32248.67%
Profit margin0.00%
Return on equity-58.96%
Return on assets-35.66%
Debt / equity1.58
Current ratio8.36
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $893.00K | $76.00K | $0 | $0 | +1,075.0% |
| Operating revenue | $893.00K | $76.00K | $0 | $0 | +1,075.0% |
| Research & development | $114.12M | $127.67M | $106.71M | $82.07M | -10.6% |
| Selling, general & admin | $51.78M | $56.08M | $44.81M | $70.94M | -7.7% |
| Total operating expense | $165.90M | $183.75M | $151.52M | $153.01M | -9.7% |
| Operating income | -$165.01M | -$183.68M | -$151.52M | -$153.01M | +10.2% |
| Net interest income | $13.81M | $19.74M | $22.07M | $5.77M | -30.1% |
| Pre-tax income | -$151.20M | -$163.93M | -$129.45M | -$147.24M | +7.8% |
| Tax provision | $414.00K | -$598.00K | $6.00M | $896.00K | +169.2% |
| Net income | -$68.99M | -$61.19M | -$35.47M | -$108.03M | -12.7% |
| Net income to common | -$68.99M | -$61.19M | -$35.47M | -$108.03M | -12.7% |
| Basic EPS | -0.52 | -0.62 | -0.57 | -0.23 | +16.1% |
| Diluted EPS | -0.52 | -0.62 | -0.57 | -0.23 | +16.1% |
| EBIT | -$151.19M | -$163.92M | -$129.44M | -$147.02M | +7.8% |
| EBITDA | -$144.62M | -$158.49M | -$125.59M | -$143.99M | +8.8% |
| Basic shares | 133.94M | 97.92M | 61.71M | 61.54M | +36.8% |
| Diluted shares | 133.94M | 97.92M | 61.71M | 61.54M | +36.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $108.54M | $99.12M | $60.65M | $490.25M | — | +9.5% |
| Cash & short-term investments | $270.02M | $358.29M | $362.95M | $490.25M | — | -24.6% |
| Total current assets | $280.68M | $395.88M | $374.15M | $504.72M | — | -29.1% |
| Property, plant & equipment | $54.90M | $45.19M | $46.41M | $13.06M | — | +21.5% |
| Goodwill & intangibles | — | — | $0 | $213.00K | $428.00K | — |
| Total assets | $335.57M | $441.07M | $420.55M | $518.00M | — | -23.9% |
| Total current liabilities | $30.74M | $36.22M | $25.04M | $10.87M | — | -15.1% |
| Total debt | $4.04M | $3.24M | $4.41M | $2.40M | — | +24.7% |
| Total liabilities | $34.78M | $39.44M | $29.22M | $13.06M | — | -11.8% |
| Retained earnings | -$1.27B | -$1.20B | -$1.14B | -$1.10B | — | -5.7% |
| Shareholder equity | -$1.01B | -$994.95M | -$1.10B | -$1.10B | — | -1.6% |
| Working capital | $249.94M | $359.67M | $349.11M | $493.85M | — | -30.5% |
| Net tangible assets | -$1.01B | -$994.95M | -$1.10B | -$1.10B | — | -1.6% |
| Shares issued | 141.81M | 128.05M | 59.88M | 61.54M | — | +10.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$151.61M | -$163.34M | -$135.45M | -$148.13M | +7.2% |
| Depreciation & amortisation | $6.58M | $5.43M | $3.85M | $3.04M | +21.0% |
| Stock-based compensation | $25.34M | $29.37M | $30.85M | $74.47M | -13.7% |
| Change in working capital | $1.28M | $3.96M | $16.67M | -$6.46M | -67.6% |
| Operating cash flow | -$120.12M | -$126.35M | -$90.07M | -$77.09M | +4.9% |
| Capital expenditure | -$15.20M | -$29.51M | -$34.20M | -$1.85M | +48.5% |
| Investing cash flow | $103.97M | $20.41M | -$329.98M | -$1.74M | +409.3% |
| Share buybacks | $0 | $0 | -$9.50M | $0 | — |
| Financing cash flow | $25.57M | $144.41M | -$9.55M | $548.52M | -82.3% |
| Free cash flow | -$135.31M | -$155.86M | -$124.27M | -$78.94M | +13.2% |
| End cash position | $108.54M | $99.12M | $60.65M | $490.25M | +9.5% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $226.00K | $225.00K | $217.00K | $221.00K | $230.00K | +0.4% |
| Operating revenue | $226.00K | $225.00K | $217.00K | $221.00K | $230.00K | +0.4% |
| Research & development | $33.84M | $34.16M | $26.82M | $25.88M | $27.26M | -0.9% |
| Selling, general & admin | $11.32M | $11.44M | $11.94M | $14.05M | $14.36M | -1.1% |
| Total operating expense | $45.16M | $45.60M | $38.76M | $39.93M | $41.62M | -1.0% |
| Operating income | -$44.93M | -$45.37M | -$38.54M | -$39.71M | -$41.39M | +1.0% |
| Net interest income | $2.31M | $2.93M | $3.26M | $3.59M | $4.03M | -21.2% |
| Pre-tax income | -$42.62M | -$42.44M | -$35.28M | -$36.12M | -$37.36M | -0.4% |
| Tax provision | $0 | -$1.58M | $560.00K | $848.00K | $591.00K | +100.0% |
| Net income | -$20.04M | -$19.23M | -$16.47M | -$16.55M | -$16.73M | -4.2% |
| Net income to common | -$20.04M | -$19.23M | -$16.47M | -$16.55M | -$16.73M | -4.2% |
| Basic EPS | -0.14 | — | -0.12 | -0.13 | -0.13 | — |
| Diluted EPS | -0.14 | — | -0.12 | -0.13 | -0.13 | — |
| EBIT | -$42.61M | -$42.44M | -$35.28M | -$36.12M | -$37.36M | -0.4% |
| EBITDA | -$40.95M | -$40.60M | -$33.61M | -$34.65M | -$35.76M | -0.9% |
| Basic shares | 141.93M | — | 134.99M | 130.73M | 126.98M | — |
| Diluted shares | 141.93M | — | 134.99M | 130.73M | 126.98M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $101.89M | $108.54M | $95.32M | $84.94M | $97.81M | -6.1% |
| Cash & short-term investments | $224.94M | $270.02M | $271.73M | $294.73M | $328.50M | -16.7% |
| Total current assets | $234.90M | $280.68M | $299.99M | $324.44M | $359.66M | -16.3% |
| Property, plant & equipment | $57.88M | $54.90M | $51.62M | $47.69M | $46.40M | +5.4% |
| Total assets | $292.78M | $335.57M | $351.61M | $372.13M | $406.06M | -12.8% |
| Total current liabilities | $25.93M | $30.74M | $29.06M | $28.26M | $32.81M | -15.6% |
| Total debt | $3.78M | $4.04M | $4.24M | $4.42M | $3.37M | -6.3% |
| Total liabilities | $29.68M | $34.78M | $33.27M | $32.68M | $36.08M | -14.7% |
| Retained earnings | -$1.29B | -$1.27B | -$1.25B | -$1.23B | -$1.22B | -1.6% |
| Shareholder equity | -$1.02B | -$1.01B | -$1.01B | -$1.00B | -$998.55M | -1.2% |
| Working capital | $208.97M | $249.94M | $270.93M | $296.18M | $326.85M | -16.4% |
| Net tangible assets | -$1.02B | -$1.01B | -$1.01B | -$1.00B | -$998.55M | -1.2% |
| Shares issued | 141.98M | 141.81M | 135.98M | 133.42M | 129.54M | +0.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$42.62M | -$40.85M | -$35.84M | -$36.97M | -$37.95M | -4.3% |
| Depreciation & amortisation | $1.66M | $1.84M | $1.67M | $1.47M | $1.60M | -9.7% |
| Stock-based compensation | $4.95M | $5.70M | $6.68M | $6.54M | $6.42M | -13.3% |
| Change in working capital | -$5.25M | $757.00K | $1.30M | -$1.89M | $1.11M | -793.9% |
| Operating cash flow | -$41.68M | -$32.51M | -$26.60M | -$31.42M | -$29.59M | -28.2% |
| Capital expenditure | -$3.79M | -$5.75M | -$5.20M | -$3.11M | -$1.14M | +34.2% |
| Investing cash flow | $34.83M | $28.09M | $29.02M | $18.57M | $28.29M | +24.0% |
| Financing cash flow | $215.00K | $17.63M | $7.96M | -$14.00K | -$12.00K | -98.8% |
| Free cash flow | -$45.47M | -$38.27M | -$31.79M | -$34.53M | -$30.73M | -18.8% |
| End cash position | $101.89M | $108.54M | $95.32M | $84.94M | $97.81M | -6.1% |
Options analytics
Put / call volume
0.47
Call-heavy session
Put / call open interest
0.07
Positioning, not flow
Max pain
1.50
-6.8% from spot
ATM implied vol
268.8%
Nearest strike to spot
Skew (10% OTM)
+152.3%
Puts bid over calls
Call volume
45
Contracts, this expiry
Put volume
21
Contracts, this expiry
Heaviest call OI
2.00
51 contracts
Heaviest put OI
1.50
6 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.14 | -0.15 | -8.7% |
| Dec 2025 | -0.15 | -0.14 | +7.3% |
| Sep 2025 | -0.14 | -0.12 | +17.2% |
| Jun 2025 | -0.14 | -0.13 | +10.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.14 | 5 | $149.00K | -32.6% |
| Next quarter | -0.14 | 5 | $453.40K | +101.5% |
| Current year | -0.56 | 5 | $507.14K | -43.2% |
| Next year | -0.59 | 5 | $494.20K | -2.6% |
Analyst targets & ownership
Mean target$6.25
High target$12.00
Low target$1.00
Implied upside293.08%
Analyst count6
ConsensusBUY
Strong buy / Buy0 / 4
Hold2
Sell / Strong sell0 / 1
Held by insiders46.45%
Held by institutions26.28%
Institutions holding100
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1.48
+7.40% from price
SMA 20
1.53
+4.94% from price
SMA 50
1.65
-2.70% from price
SMA 100
1.75
-9.10% from price
SMA 200
1.99
-19.00% from price
EMA 12
1.50
+6.08% from price
EMA 26
1.55
+2.53% from price
EMA 50
1.62
-2.14% from price
RSI (14)
53.3
Neutral
MACD (12,26,9)
-0.05
Hist 0.00
ATR (14)
0.11
6.92% of price
Realised vol 30D
71.2%
Annualised
Bollinger upper
1.74
20, 2σ
Bollinger lower
1.33
20, 2σ
50 / 200 cross
Death
1.65 vs 1.99
Trend bias
Below 200
-19.00%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
2.18
More volatile than market
Correlation to SPY
0.34
Loosely linked
Realised vol 30D
71.2%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-59.7%
Peak to trough
Max drawdown 5Y
-96.3%
Peak to trough
ATR 14
0.11
6.92% of price
Beta (reported)
1.72
5Y monthly, from filing
Short interest
Shares short
20.71M
Prior 19.43M
Change vs prior
+6.6%
Shorts adding
% of float
13.65%
Elevated
% of shares out
10.09%
Against total outstanding
Days to cover
17.0
Crowded exit
Float
160.49M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 18, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Dec 16, 25 | HC Wainwright & Co. | INITIATED | — | Buy |
| Jul 15, 25 | UBS | MAINTAINED | Buy | Buy |
| Jul 14, 25 | Guggenheim | MAINTAINED | Buy | Buy |
| Jul 9, 25 | Citigroup | MAINTAINED | Buy | Buy |
| Jun 30, 25 | B of A Securities | DOWNGRADE | Neutral | Underperform |
| Sep 30, 24 | JP Morgan | INITIATED | — | Neutral |
| Sep 10, 24 | Guggenheim | INITIATED | — | Buy |
| Sep 4, 24 | B of A Securities | MAINTAINED | Neutral | Neutral |
| Jun 10, 24 | Jefferies | MAINTAINED | Buy | Buy |
| May 29, 24 | B of A Securities | MAINTAINED | Neutral | Neutral |
| Jan 2, 24 | B of A Securities | DOWNGRADE | Buy | Neutral |
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-10
Corporate Changes & Voting Matters
8-K · 2026-05-29
Corporate Changes & Voting Matters
8-K · 2026-05-15
Proxy Statements
DEF 14A · 2026-04-17
Offering Registrations
S-8 · 2026-03-18
Corporate Changes & Voting Matters
8-K · 2026-02-02
Corporate Changes & Voting Matters
8-K · 2026-01-12
Periodic Financial Reports
10-Q · 2025-11-10
Headlines
Prokidney Insider Sold Shares Worth $1,067,773, According to a Recent SEC Filing
MT Newswires · 3d ago
ProKidney Corp. (PROK) Reports Q2 Loss, Misses Revenue Estimates
Zacks · 13d ago
ProKidney Reports Second Quarter 2026 Financial Results and Business Highlights
GlobeNewswire · 13d ago
Why ProKidney (PROK) Is Building Its Bull Case Around Rilparencel’s Accelerated Approval Path
Insider Monkey · 67d ago
Identiv And Two Other Penny Stocks To Watch Closely
Simply Wall St. · 79d ago
ProKidney Appoints Kenneth Locke as Chief Technical Officer
GlobeNewswire · 82d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.